1. Apostolopoulos, V., Osinski, C. & McKenzie, I. F. C. (1998). MUC1 cross-reactive galα (1,3) gal antibodies in humans switch immune responses from cellular to humoral. Nature Med 4: 315–320.
2. Ceriani, R. L., Peterson, J. A., Lee, J. Y., Moncada, R. & Blank, E. W. (1983). Characterization of cell surface antigens of human mammary epithilial cells with monoclonal antibodies, prepared against human milk fat globule. Somat Cell Genetics 9: 415–427.
3. Devine, P. L., Clark, B. A., Birell, G. W., Layton, G. T., Ward, B. G., Alegood, P. F. & McKenzie, I. F. C. (1991). The breast tumor-associated epitope defined by MoAb 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res 51: 5826–5836.
4. Gilewski, T., Dickler, M., Adluri, R., Zhang, S., Houghton, A., Norton, L. & Livingston, P. O. (1998). Vaccination of high risk breast cancer patients (PTS) with MUC-1 (32aa) keyhole limpet hemocyarin (KLH) conjugate plus QS-21: Preliminary results. American Society of Clinical Oncology 17: 16–70.
5. Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillet, C. & Taylor-Papadimitrou, J. A. (1989). Core protein epitope of the polymorphic epithelial mucin detected by MoAb SM-3 is selectively expressed in a range of primary carcinomas. Int J Cancer 43: 1072–1076.